Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsInfulenza vaccine

    Infulenza Vaccine

    Jump to

    • Cadila Health up 3% on product launch & USFDA nod to skin drug

      Cadila‘s subsidiary, Zydus Cadila, received regulatory approvals to launch tetravalent inactivated influenza vaccine for seasonal flu in India. Meanwhile, Zydus received the approval from US Food and Drug Administration (FDA) for Linezolid tablets. These are used to treat skin infections and pneumonia.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347